Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Eardley, I.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Pathophysiology of erectile dysfunction

Ian Eardley

St James University Hospital, Beckett Street, Leeds, LS9 7TF, UK, ian.eardley{at}btinternet.com

New knowledge regarding the importance of vascular, endocrine, cellular, neural and psychological mechanisms in the pathophysiology of erectile dysfunction has led to changes in the theories of causation. Additionally several drugs can impair sexual function. These topics are reviewed herein.

Key Words: pathophysiology • diabetes • risk factors • erectile dysfunction.

The British Journal of Diabetes & Vascular Disease, Vol. 2, No. 4, 272-276 (2002)
DOI: 10.1177/14746514020020040701
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
I. W Campbell
Erectile dysfunction in diabetes mellitus: a risk factor for cardiovascular disease
The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 212 - 213.
[PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
F. Jamieson, J. Chalmers, C. Duncan, R. J Prescott, and I. W Campbell
Erectile dysfunction in type 1 diabetic males
The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 232 - 234.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
S. Hood and M. Kirby
Review: PDE-5 inhibitors -- a summary
The British Journal of Diabetes & Vascular Disease, November 1, 2004; 4(6): 383 - 386.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
S. Hood and M. Kirby
Review: Risk factor assessment of erectile dysfunction
The British Journal of Diabetes & Vascular Disease, May 1, 2004; 4(3): 157 - 161.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
K. J Snow
Erectile dysfunction in patients with diabetes mellitus -- advances in treatment with phosphodiesterase type 5 inhibitors
The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 282 - 287.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
P. Kell, J. Dean, and D. Ralph
Apomorphine SL in the treatment of erectile dysfunction
The British Journal of Diabetes & Vascular Disease, July 1, 2002; 2(4): 296 - 300.
[Abstract] [PDF]